Samantha A. Lasser
Mannheim, BW 68167, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma.
Journal: International journal of molecular sciences
Published: March 28, 2024
Myeloid-derived suppressor cells in cancer and cancer therapy.
Journal: Nature reviews. Clinical oncology
Published: November 29, 2023
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs.
Journal: Oncoimmunology
Published: August 18, 2023
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target.
Journal: The Journal of clinical investigation
Published: July 03, 2023
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
Journal: Journal for immunotherapy of cancer
Published: September 01, 2022
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2.
Journal: Frontiers in immunology
Published: August 05, 2022
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.
Journal: Journal for immunotherapy of cancer
Published: February 21, 2022
Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization.
Journal: International journal of cancer
Published: March 31, 2021
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy.
Journal: Cellular immunology
Published: October 23, 2020
Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles.
Journal: International journal of molecular sciences
Published: July 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026